Akso Health Group (AHG) is a Healthcare company in the Medical Distribution industry. It has a market capitalization of $1.16B and a free-cash-flow yield of -19.3%. Over the most recent reported fiscal year, revenue declined 6.4% and free cash flow per share fell 7369.3%. Nama's AI scorecard rates it Sell, 2.3 out of 10. On 12-month momentum it ranks in the lagging band of its market.
AI scorecard
Sell · 2.3/10
Clearly negative, short of the bottom band. As of Nov 6, 2026.
Momentum
Lagging · -28.4% over 12 months ex. last
Second-worst fifth of its market on the past year's move.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-72.4%
How far the last close sits under the highest price of the past five years.
Nama's AI scorecard currently rates Akso Health Group Sell (2.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
Is AHG Shariah compliant?
Nama's AAOIFI-style screen reads Akso Health Group as Can't Tell. A figure the screen needs is missing, so it can't tell.